Home

 

 

In This Section

AIPLA 2027 Annual Meeting

October 28 to 30, 2027

Location

Westin Washington, DC, Downtown
999 9th Street, NW

Washington, DC, USA

To be held at the Westin Washington, DC, Downtown

Executive Committee Meeting on Tuesday October 26, 2:00 - 5:00 PM
Board of Directors Meeting on Wednesday, October 27, 10 AM - 12 Noon and Saturday, October 30, 12:30 - 4:00 PM
Board/Committee Leadership Meeting, Wednesday, October 27, 1:00 - 5:00 PM
Board/Committee Leadership Networking Event, Wednesday, October 27, 6:00 - 7:30 PM

General Programming and Social Events October 28 - 30.

Join us as we bring IP professionals together to learn and connect.  More information coming soon!

 

RESERVATION LINK:  To be provided

Group Room Rate: $345 plus applicable taxes (currently 15.95%).

Check-in: 4:00PM
Check-out: 11:00AM

Cancellation - 72 hours in advance

Cut off date for Room Reservations -- Monday, October 4, 2027.

NOTE:  AIPLA does NOT engage any third party vendors to assist with room reservations.  All room reservations should be made directly using the Reservation link above, or by contacting the Westin directly.

Sponsorship or exhibiting opportunities, information coming soon.

Add to:

 

 

News

  • AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”

    June 15, 2026

    Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.”
  • Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

    June 4, 2026

    On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry.
  • TermDisc-Comments-March21-logo AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance

    May 15, 2026

    Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.
  • AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment

    May 8, 2026

    Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule.
  • TermDisc-Comments-March21-logo AIPLA Submits Comments on the Enlarged Board of Appeal’s 11 Preliminary Opinion in G 1/25

    May 1, 2026

    Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments.